Corporate Tech Investors

Knight Therapeutics

Knight Therapeutics is a corporate VC that partners with startup ventures that can advance its organizational interests.

Venture Investor Overview

Contact Information

Background Information

Overview

Knight Therapeutics Inc. (TSX: GUD) is a publicly-traded, specialty pharmaceutical company focused on acquiring, in-licensing, selling and marketing innovative prescription and over-the-counter pharmaceutical products. Knight conducts late-stage clinical development on low risk, low expense product opportunities. All of Knight's products are sourced through partnerships.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

2/29/2020

Transaction History

Our records indicate that Knight Therapeutics invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Jonathan Goodman

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Knight Therapeutics has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

KMS Technology | Knowles

Share this article

About Our Corporate Tech Investing Database

This corporate tech investor profile is powered by VentureDeal.com, a market leader in strategic investor transaction data for corporations that invest in the tech sector.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary